Product Information

HYDROXYZINE HCL 25 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.0324 per EA under NDC 60687067501. Its NADAC has been published 205 times since Dec 14, 2022.

FDA first approved this application on Jan 10, 1986. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

HYDROXYZINE HCL 25 MG TABLET

Hydroxyzine Hydrochloride
$0.0324per EA

Strength

25 mg/1

NDC

60687067501

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

HYDROXYZINE DIHYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA088618

FDA Approved

1/10/1986

TE Code

AB

On Market Since

10/20/2022

Pharmacological Classes

Antihistamine
Histamine Receptor Antagonists

Price Statistics

The NADAC for HYDROXYZINE HCL 25 MG TABLET has been published 205 times since Dec 14, 2022, and over the history we have for it it has declined 35.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0324 per EA
All-time high$0.0517 (Jun 14, 2023)
All-time low$0.0324 (Oct 21, 2026)
52-week high$0.0356
52-week low$0.0324
Median price$0.0413
Average price$0.0411
Largest weekly change-27.4% (Nov 20, 2024)
Weeks tracked205
Tracking sinceDec 14, 2022

Price History

1W

0.0%

1M

-0.4%

3M

-7.4%

6M

-6.2%

1Y

-9.0%

3Y

-21.5%

5Y

N/A

All

-35.6%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROXYZINE HCL 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE HCL 25 MG TABLET, manufactured by American Health Packaging, is $0.0324 per EA (NDC 60687067501), effective Nov 11, 2026.

How has the price of HYDROXYZINE HCL 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROXYZINE HCL 25 MG TABLET has declined 35.6%. It has been tracked across 205 weekly CMS publications since Dec 14, 2022.

What are the highest and lowest recorded NADAC prices for HYDROXYZINE HCL 25 MG TABLET?

Since Dec 14, 2022, the NADAC for HYDROXYZINE HCL 25 MG TABLET has ranged from a low of $0.0324 (Oct 21, 2026) to a high of $0.0517 (Jun 14, 2023), with a median of $0.0413 per EA.

Are there cheaper alternatives to HYDROXYZINE HCL 25 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROXYZINE HCL 25 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures HYDROXYZINE HCL 25 MG TABLET?

HYDROXYZINE HCL 25 MG TABLET (NDC 60687067501) is labeled by American Health Packaging, and CMS classifies it as a generic product.